Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-031017

SVP & General Counsel sold 1,529 shares at $22.51 ($34,418)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew SVP & General Counsel 2020-05-18 Sale −1,529 $22.51 $34,418 52,418 D: show line 1 in the form
Open-market sales · 1,529 sh · avg $22.51 · $34,418
Loading xslF345X03/doc4.xml…